Effect of Inverse Ratio Ventilation During Induction of General Anesthesia on Safe Apnea Time in Obese Patients
1 other identifier
interventional
40
1 country
2
Brief Summary
The purpose of this study is to investigate the clinical application value of inverse ratio ventilation in obese patients during induction of general anesthesia by studying the effect of inverse ratio ventilation on the safe apnea time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Aug 2020
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 17, 2020
CompletedFirst Submitted
Initial submission to the registry
October 11, 2020
CompletedFirst Posted
Study publicly available on registry
November 13, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFebruary 17, 2025
October 1, 2020
1.4 years
October 11, 2020
February 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Safe Apnea Time
The safe apnea time was defined as that period of time during which the arterial saturation as measured by pulse oximetry remained at or above 93% .
The arterial saturation as measured by pulse oximetry remained at or above 93% after endotracheal intubation immediately.
Secondary Outcomes (3)
EtO2
After 3 minutes of preoxygenation After 5 minutes of noninvasive positive pressure ventilation
EtO2
After 3 minutes of noninvasive positive pressure ventilation
EtO2
After 5 minutes of noninvasive positive pressure ventilation
Study Arms (2)
Group 1:2
OTHERPatients in the control group had noninvasive positive pressure ventilation with inspiratory-to-expiratory (I : E) ratio of 1:2.
Group 2:1
OTHERPatients in the IRV group had noninvasive positive pressure ventilation with inspiratory-to-expiratory (I : E) ratio of 2:1.
Interventions
After preoxygenation and induction of anesthesia, noninvasive positive pressure ventilation with inspiratory-to-expiratory (I : E) ratio of 1:2 for 5 min before endotracheal intubation.
After preoxygenation and induction of anesthesian, noninvasive positive pressure ventilation with inspiratory-to-expiratory (I : E) ratio of 2:1 for 5 min before endotracheal intubation.
Eligibility Criteria
You may qualify if:
- Obese patients, aged 18-65 years, of either gender, ASA grade II-III, body mass index (BMI) \> 30 kg / m2, scheduled for general anesthesia under tracheal intubation, signed informed consent.
You may not qualify if:
- Patients who need rapid sequence induction (RSI); patients with expected difficult airway; severe chronic respiratory diseases, such as tuberculosis, bronchitis, bronchial asthma and COPD; patients with severe cardiovascular diseases, such as severe ischemic heart disease and pulmonary hypertension; patients with severe cerebrovascular diseases, such as cerebral hemorrhage and cerebral infarction; patients with abnormal basal metabolic rate, such as pregnancy, thyrotoxicosis, pheochromocytoma; and severe stomach reflux disease; patients with abnormal hemoglobin and hematocrit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
General Hospital of Ningxia Medical University
General Hospital of Ningxia Medical University, Ningxia, 750004, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, 750004, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 11, 2020
First Posted
November 13, 2020
Study Start
August 17, 2020
Primary Completion
January 1, 2022
Study Completion
January 1, 2022
Last Updated
February 17, 2025
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share